Taro Watabe

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol.

Phase Ib/II trial to evaluate the safety and efficacy of atezolizumab and bevacizumab as adjuvant therapy following carbon-ion radiotherapy in hepatocellular carcinoma (VANGUARD): study protocol.

Journal: BMJ open
Published: June 02, 2026

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma.

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma.

Journal: Cancer medicine
Published: November 30, 2025

Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study.

Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real-World Clinical Study.

Journal: Cancer medicine
Published: March 31, 2025

Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 26, 2023

Apelin expression is downregulated in T cells in a murine model of chronic colitis.

Apelin expression is downregulated in T cells in a murine model of chronic colitis.

Journal: Biochemical and biophysical research communications
Published: January 10, 2023

Corrigendum to "CEACAM1 specifically suppresses B cell receptor signaling-mediated activation".

Corrigendum to "CEACAM1 specifically suppresses B cell receptor signaling-mediated activation".

Journal: Biochemical and biophysical research communications
Published: May 17, 2021

CEACAM1 specifically suppresses B cell receptor signaling-mediated activation.

CEACAM1 specifically suppresses B cell receptor signaling-mediated activation.

Journal: Biochemical and biophysical research communications
Published: November 23, 2020

Immunoglobulin A-specific deficiency induces spontaneous inflammation specifically in the ileum.

Immunoglobulin A-specific deficiency induces spontaneous inflammation specifically in the ileum.

Journal: Gut
Published: August 22, 2020

A case of cytomegalovirus esophagitis during topical steroid therapy for eosinophilic esophagitis.

A case of cytomegalovirus esophagitis during topical steroid therapy for eosinophilic esophagitis.

Journal: Clinical journal of gastroenterology
Published: March 07, 2020

Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopy.

Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopy.

Journal: Clinical journal of gastroenterology
Published: September 13, 2018

B cell activation in the cecal patches during the development of an experimental colitis model.

B cell activation in the cecal patches during the development of an experimental colitis model.

Journal: Biochemical and biophysical research communications
Published: January 07, 2018

MKL1 expressed in macrophages contributes to the development of murine colitis.

MKL1 expressed in macrophages contributes to the development of murine colitis.

Journal: Scientific reports
Published: February 03, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026